scholarly article | Q13442814 |
P50 | author | Christoph Handschin | Q14865377 |
Aurel B Leuchtmann | Q92093364 | ||
P2860 | cites work | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids | Q24306330 | ||
Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers? | Q26775758 | ||
Caloric restriction and exercise "mimetics'': Ready for prime time? | Q26776446 | ||
Nutritional supplements in support of resistance exercise to counter age-related sarcopenia | Q26801256 | ||
Optimizing IGF-I for skeletal muscle therapeutics | Q26825444 | ||
Vitamin D signaling in myogenesis: potential for treatment of sarcopenia | Q26849642 | ||
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration | Q28262319 | ||
Systematic review: the safety and efficacy of growth hormone in the healthy elderly | Q28283624 | ||
Effects of human growth hormone in men over 60 years old | Q28288413 | ||
Basal muscle amino acid kinetics and protein synthesis in healthy young and older men | Q28353882 | ||
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial | Q30438239 | ||
Effects of Testosterone Treatment in Older Men. | Q30833686 | ||
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging | Q31831299 | ||
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS): study protocol for a randomized controlled trial | Q33604458 | ||
Therapeutic Potential of Targeting the Ghrelin Pathway | Q33624632 | ||
ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. | Q33636677 | ||
Role of Nuclear Receptors in Exercise-Induced Muscle Adaptations. | Q33751474 | ||
The GH/IGF-1 axis in ageing and longevity | Q33817029 | ||
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease | Q33983615 | ||
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. | Q34029187 | ||
A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. | Q50940837 | ||
Indomethacin in combination with exercise leads to muscle and brain inflammation in mice. | Q51013730 | ||
Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults - The PROVIDE study. | Q51164084 | ||
The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: A systematic review and meta-analysis of randomized, placebo-controlled trials. | Q51760936 | ||
Effect of Protein Intake on Lean Body Mass in Functionally Limited Older Men: A Randomized Clinical Trial. | Q51763693 | ||
Diet Quality and Sarcopenia in Older Adults: A Systematic Review. | Q51765431 | ||
Skeletal muscle adaptation to immobilization and subsequent retraining in elderly men: No effect of anti-inflammatory medication. | Q53604191 | ||
Alterations in the expression of mRNAs and proteins that code for species relevant to eIF2B activity after an acute bout of resistance exercise | Q53649427 | ||
Activation of mTORC1 by leucine is potentiated by branched-chain amino acids and even more so by essential amino acids following resistance exercise. | Q53790846 | ||
Age-related differences in lean mass, protein synthesis and skeletal muscle markers of proteolysis after bed rest and exercise rehabilitation. | Q55053241 | ||
Inflammaging: a new immune-metabolic viewpoint for age-related diseases | Q56363344 | ||
Nutritional Assessment and Intervention to Prevent and Treat Malnutrition for Fall Risk Reduction in Elderly Populations | Q57151368 | ||
Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis | Q57187355 | ||
Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials | Q58082954 | ||
Impact of drugs with anti-inflammatory effects on skeletal muscle and inflammation: A systematic literature review | Q58118276 | ||
Disease or not, aging is easily treatable | Q60054020 | ||
Equivalent Hypertrophy and Strength Gains in β-Hydroxy-β-Methylbutyrate- or Leucine-supplemented Men | Q60302128 | ||
Prolonged absence of myostatin reduces sarcopenia | Q60462848 | ||
Vitamin D receptor gene polymorphisms modify the association of serum 25-hydroxyvitamin D levels with handgrip strength in the elderly in Northern China | Q64136456 | ||
Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I | Q73620065 | ||
Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study | Q77835138 | ||
Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo | Q81196329 | ||
Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction | Q81306478 | ||
MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study | Q82413237 | ||
Perspective: Protein Requirements and Optimal Intakes in Aging: Are We Ready to Recommend More Than the Recommended Daily Allowance? | Q88319142 | ||
Muscle morphology and performance in master athletes: A systematic review and meta-analyses | Q88532342 | ||
Omega-3 fatty acid supplementation attenuates skeletal muscle disuse atrophy during two weeks of unilateral leg immobilization in healthy young women | Q90982339 | ||
Muscle Wasting Diseases: Novel Targets and Treatments | Q91156978 | ||
Improving Dietary Protein Quality Reduces the Negative Effects of Physical Inactivity on Body Composition and Muscle Function | Q91250546 | ||
Sarcopenia: revised European consensus on definition and diagnosis | Q91971990 | ||
Sarcopenia: Aging-Related Loss of Muscle Mass and Function | Q93067806 | ||
Caloric restriction and its mimetics | Q34049440 | ||
Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis | Q34107533 | ||
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study | Q34113431 | ||
Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women | Q34179131 | ||
The ACE gene and human performance: 12 years on. | Q34187481 | ||
Vitamin D status affects strength gains in older adults supplemented with a combination of β-hydroxy-β-methylbutyrate, arginine, and lysine: a cohort study | Q34205375 | ||
Effects of vitamin D in the elderly population: current status and perspectives | Q34274418 | ||
Clinical effectiveness of protein and amino acid supplementation on building muscle mass in elderly people: a meta-analysis | Q34277451 | ||
Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy | Q34340407 | ||
Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial | Q34493034 | ||
n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases | Q34569101 | ||
Losartan improves measures of activity, inflammation, and oxidative stress in older mice. | Q34616302 | ||
Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. | Q34720131 | ||
Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids | Q34802103 | ||
Effects of an oral growth hormone secretagogue in older adults | Q34931335 | ||
Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. | Q35032969 | ||
Effect of growth hormone on aging connective tissue in muscle and tendon: gene expression, morphology, and function following immobilization and rehabilitation | Q35043433 | ||
Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia | Q35118372 | ||
Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study | Q35258897 | ||
Effect of age on basal muscle protein synthesis and mTORC1 signaling in a large cohort of young and older men and women | Q35418071 | ||
Inflammatory mediators in the elderly | Q35766426 | ||
Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults | Q35781227 | ||
Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial | Q36015736 | ||
The Effect of a 12-Week Omega-3 Supplementation on Body Composition, Muscle Strength and Physical Performance in Elderly Individuals with Decreased Muscle Mass. | Q36102337 | ||
Leucine partially protects muscle mass and function during bed rest in middle-aged adults | Q36521506 | ||
Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia | Q36576317 | ||
Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults | Q36595343 | ||
Unlocking the wasting enigma: Highlights from the 8th Cachexia Conference | Q36706618 | ||
Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise | Q36764607 | ||
Rapamycin does not affect post-absorptive protein metabolism in human skeletal muscle | Q36924317 | ||
The role of exercise and PGC1alpha in inflammation and chronic disease | Q36984669 | ||
Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. | Q37020043 | ||
A randomized study on the effect of vitamin D₃ supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women | Q37361785 | ||
Effects of myostatin deletion in aging mice | Q37393064 | ||
Sex differences in the effect of fish-oil supplementation on the adaptive response to resistance exercise training in older people: a randomized controlled trial | Q37531708 | ||
An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy | Q37546849 | ||
Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. | Q37798195 | ||
Factors influencing vitamin D status | Q37850699 | ||
Chronic low-grade inflammation and age-related sarcopenia. | Q37959664 | ||
Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis. | Q38058393 | ||
Signaling pathways controlling skeletal muscle mass | Q38162987 | ||
Making new contacts: the mTOR network in metabolism and signalling crosstalk | Q38189969 | ||
The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials | Q38230581 | ||
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases | Q38647444 | ||
The effect of combined resistance exercise training and vitamin D3 supplementation on musculoskeletal health and function in older adults: a systematic review and meta-analysis. | Q38669251 | ||
A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. | Q38683478 | ||
Inflammation and sarcopenia: A systematic review and meta-analysis | Q38775810 | ||
The relationship between nutrition and frailty: Effects of protein intake, nutritional supplementation, vitamin D and exercise on muscle metabolism in the elderly. A systematic review. | Q38820270 | ||
Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe | Q38890081 | ||
Androgen-mediated regulation of skeletal muscle protein balance | Q38941997 | ||
High mTORC1 signaling is maintained, while protein degradation pathways are perturbed in old murine skeletal muscles in the fasted state | Q39655772 | ||
Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. | Q39694105 | ||
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial | Q40376778 | ||
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting | Q40891663 | ||
Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. | Q42444632 | ||
Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. | Q42462834 | ||
No effect of anti-inflammatory medication on postprandial and postexercise muscle protein synthesis in elderly men with slightly elevated systemic inflammation | Q42497286 | ||
Ibuprofen administration during endurance training cancels running-distance-dependent adaptations of skeletal muscle in mice | Q42808800 | ||
Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men. | Q42986801 | ||
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study | Q43198484 | ||
Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats | Q43276899 | ||
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy | Q44030256 | ||
Androgens and Women at the Menopause and Beyond | Q44429302 | ||
Vitamin D receptor expression in human muscle tissue decreases with age. | Q44767876 | ||
Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis | Q46135983 | ||
Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women | Q46467211 | ||
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study | Q46757585 | ||
A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. | Q46968639 | ||
Mechanistic Links Underlying the Impact of C-Reactive Protein on Muscle Mass in Elderly. | Q47410203 | ||
The Impact of Dietary Protein or Amino Acid Supplementation on Muscle Mass and Strength in Elderly People: Individual Participant Data and Meta-Analysis of RCT's. | Q47588608 | ||
PGC-1α affects aging-related changes in muscle and motor function by modulating specific exercise-mediated changes in old mice | Q47723638 | ||
Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls | Q47811763 | ||
High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults. | Q47915472 | ||
Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms. | Q48228971 | ||
Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway | Q48701446 | ||
Lean body mass change over 6 years is associated with dietary leucine intake in an older Danish population. | Q50569935 | ||
P304 | page(s) | 104191 | |
P577 | publication date | 2019-03-04 | |
P1433 | published in | Pharmacological Research | Q15724622 |
P1476 | title | Pharmacological targeting of age-related changes in skeletal muscle tissue | |
P478 | volume | 154 |